Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Seungtaek Kim and Meehyun Ko.
Seungtaek Kim
Connection Strength
1.421
Meehyun Ko
  1. Comparative analysis of antiviral efficacy of FDA-approved drugs against SARS-CoV-2 in human lung cells. J Med Virol. 2021 03; 93(3):1403-1408.
    View in: PubMed
    Score: 0.898
  2. TMPRSS2 and RNA-Dependent RNA Polymerase Are Effective Targets of Therapeutic Intervention for Treatment of COVID-19 Caused by SARS-CoV-2 Variants (B.1.1.7 and B.1.351). Microbiol Spectr. 2021 09 03; 9(1):e0047221.
    View in: PubMed
    Score: 0.240
  3. Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs. Antimicrob Agents Chemother. 2020 06 23; 64(7).
    View in: PubMed
    Score: 0.222
  4. Published anti-SARS-CoV-2 in vitro hits share common mechanisms of action that synergize with antivirals. Brief Bioinform. 2021 11 05; 22(6).
    View in: PubMed
    Score: 0.061
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.